Two Sigma Advisers’s Forte Biosciences FBRX Stock Holding History

Two Sigma Advisers’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-992	Closed	-$17.3K	–	2517
2024 Q1	$17.3K	Hold	992	–	–	﹤0.01%	2409
2023 Q4	$20.4K	Sell	992 -88	-8%	-$1.23K	﹤0.01%	2448
2023 Q3	$17.9K	Sell	1,080 -1,224	-53%	-$27.1K	﹤0.01%	2328
2023 Q2	$59.9K	Sell	2,304 -308	-12%	-$8K	﹤0.01%	2259
2023 Q1	$65.9K	Sell	2,612 -224	-8%	-$5.63K	﹤0.01%	2423
2022 Q4	$70.9K	Sell	2,836 -3,422	-55%	-$87.7K	﹤0.01%	2332
2022 Q3	$167K	Sell	6,258 -662	-10%	-$21K	﹤0.01%	2237
2022 Q2	$225K	Sell	6,920 -2,496	-27%	-$79.3K	﹤0.01%	2237
2022 Q1	$344K	Sell	9,416 -732	-7%	-$27.7K	﹤0.01%	2162
2021 Q4	$543K	Buy	+10,148	New	+$683K	﹤0.01%	1875
2020 Q1	–	Sell	-151	Closed	-$30K	–	2489
2019 Q4	$30K	Buy	+151	New	+$34.2K	﹤0.01%	2310

Other funds holding FBRX

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers's FBRX Position: Q2 2024 in Review

Two Sigma Advisers sold out of Forte Biosciences (FBRX) in Q2 2024, closing a stake of 992 shares — an estimated $17.3K sold.

Two Sigma Advisers first reported a position in FBRX in Q4 2019 and held it in 11 quarters. The position peaked at $543K in Q4 2021. 33 funds tracked by Wall St. Rank hold FBRX as of Q2 2024.

Two Sigma Advisers reported no remaining Forte Biosciences position as of Q2 2024 after selling out during the quarter.
Two Sigma Advisers sold 992 Forte Biosciences shares in Q2 2024, an estimated $17.3K.
Two Sigma Advisers first reported a position in Forte Biosciences in Q4 2019 and held it in 11 quarters.
Two Sigma Advisers's Forte Biosciences position peaked at $543K in Q4 2021.
33 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.